PRE 14A

OXIGENE, INC.

Company: Oncotelic Therapeutics, Inc.
Filed: April 18, 2008
Period of Report: July 23, 2008
Accession Number: 0000950135-08-002602

View Document ↗ View on SEC.gov ↗